Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > OR Providers > Urologists

Dr. Michael T. Lavelle JR., MD

Accepting New Patients

(2 Ratings)

Specializes in: Urology (Urinary Tract Disease)

Loyola University Chicago, Stritch School of Medicine (2005)

Professional interests include: interstitial cystitis, benign prostatic hyperplasia (enlarged prostate), urinary incontinence, and more.

2200 NE Neff Road Suite 302
Bend, OR 97701

(541) 706-4200

Dr. Michael T. Lavelle JR., MD is an urologist in Bend, OR specializing in urology (urinary tract disease). He graduated from Loyola University Chicago, Stritch School of Medicine in 2005 and has 19 years of experience. Dr. Michael T. Lavelle JR., MD is affiliated with St. Charles Health System, PRAXIS HEALTH PC and ST CHARLES HEALTH SYSTEM INC.

Office Locations

Address:

2200 NE Neff Road Suite 302
Bend, OR 97701

Some issues Dr. Michael T. Lavelle JR., MD can help you with:

Benign Prostatic Hyperplasia (Enlarged Prostate)

Benign prostatic hyperplasia (BPH) is a noncancerous condition in which the prostate gland becomes enlarged. BPH affects about half of men between the ages of 50 and 60, and approximately 80% of men over 80. As the prostate grows in size, it can press down on the tube where urine flows out of the body (the urethra) and cause urinary problems.

Medication can relieve mild to moderate symptoms of BPH, such as frequent urination, incomplete bladder emptying, a weak urine stream, and straining while urinating. However, other forms of treatment may be more appropriate if an individual has pain with urination, frequent urinary tract infections, or is unable to urinate. The size of the prostate and the severity of their symptoms will determine the type of treatment they need. If the prostate is not very large, doctors will likely recommend a transurethral procedure. This minimally invasive technique involves the insertion of a scope into the urethra. The most common transurethral procedures for BPH are:

Transurethral incision of the prostate or TUIP, where the surgeon uses the scope to make small cuts in the area of the prostate that meets the bladder. These cuts will open up the pathway for urine and allow it to flow with more ease.
Transurethral needle ablation or TUNA, where needles are inserted through the scope and into the prostate. The needles use radiofrequency waves to destroy excess prostate tissue.
Laser prostate ablation, where lasers pass through the scope to melt away the part of the prostate causing urine blockage.
Transurethral resection of the prostate or TURP, where the inside of the prostate is trimmed and removed one tiny piece at a time using the scope.

If the prostate is too big for a transurethral procedure, an individual may need a simple prostatectomy, which can be done in one of three ways: laparoscopic, robotic, or open. During a laparoscopic simple prostatectomy, a surgeon makes several small incisions on the belly. Then they insert a long tube with a camera into one of the cuts and surgical instruments into the others. Using the camera to see inside the belly, they carefully removes the enlarged part of the prostate. Robotic simple prostatectomy uses the same techniques as the laparoscopic method, but the surgery is done with the help of a robot. For men with very large prostates, open simple prostatectomy may be the best treatment option. This surgery differs from the other approaches in that it requires a much larger incision.

Most transurethral treatments for BPH, like TUIP, TUNA, and laser prostate ablation, are done in the doctor's office or outpatient surgery center. TURP and simple prostatectomy, however, need to be performed in the hospital and require an average stay of one to three days. Patients should wait a week before doing any strenuous activities after a TUIP, TUNA, or laser prostate ablation, and about four to six weeks after a TURP or simple prostatectomy. Although these treatments improve BPH symptoms for most patients, it is important to be aware of the risks involved, such as urine control issues, tightening of the urethra, and erectile dysfunction.

Kidney Stones

Kidney stones are hard deposits that form in the kidneys, made up of minerals that are normally present in urine. They can vary in size, from as small as a grain of sand to as large as a nickel, occasionally even larger. Sometimes they lodge in the kidney, and sometimes they break free and make their way out through the urinary tract, which can be extremely painful.

Kidney stones can be smooth or jagged and are yellow to brown in color. They are mostly comprised of the minerals calcium, oxalate, and phosphorus. Examining the stones to see what they are made of can show what caused the stone to be formed in the first place. For example, a stone made of mostly calcium, which is the most common type, can happen any time the urine becomes too concentrated due to dehydration or a blockage in the kidney. A uric acid stone forms when acid levels in the urine get too high, usually due to excessive consumption of animal protein such as meat and fish. A struvite stone is a sign of certain infections, and a cystine stone can be due to a genetic disorder that raises the risk of kidney stones.

The most common symptom of kidney stones is pain, either in the back or lower abdomen, or severe pain when urinating. There may also be blood in the urine. Treatment for kidney stones depends on how large the stone is. Very small stones can pass out of the body on their own, and they do not require treatment other than drinking adequate water and taking pain killers. Larger stones need to be broken apart and removed. The main treatment options are:

Shock wave lithotripsy, which uses sound wave vibrations to break apart the stone
Percutaneous nephrolithotomy, or the use of a very tiny tool (like a wire inserted through the back) to break apart and remove the stone
Ureteroscopy, a thin tube inserted through the urethra and bladder to the stone, where tiny tools can grasp the stone and remove

People who have had one kidney stone are at risk of developing another. To reduce this risk, patients are given instructions specific to the type of stone they developed. Generally the instructions will include drinking more water to dilute the urine, but it may also involve lowering sodium intake or eating less meat.

blood draw	19
doctor visit	583
hospital care	30
inpatient care	30
lab tests	318
minimally invasive procedures	82
urologic procedures	257

**Gender**
Male	256
Female	76

**Ethnicity**
Non-Hispanic White	304
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	135
From 75 to 84	114
85 and over	41
Less than 65	42

Hypertension	54
High Cholesterol	38
Stroke	5
Ischemic Heart Disease	30
Depression	19
Chronic Kidney Disease	28
Asthma	6
Osteoperosis	6
Atrial Fibrilation	12
Heart Failure	16
Chronic Obstructive Pulmonary Disease	11
Diabetes	20
Dementia	8
Cancer	23

blood draw	15
doctor visit	698
hormone therapy	21
hospital care	47
inpatient care	47
lab tests	309
minimally invasive procedures	98
urologic procedures	357

**Gender**
Male	328
Female	91

**Ethnicity**
Non-Hispanic White	378
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	189
From 75 to 84	125
85 and over	51
Less than 65	54

Hypertension	56
High Cholesterol	42
Stroke	5
Ischemic Heart Disease	34
Depression	20
Chronic Kidney Disease	28
Asthma	5
Osteoperosis	5
Atrial Fibrilation	14
Heart Failure	17
Chronic Obstructive Pulmonary Disease	11
Diabetes	24
Dementia	9
Cancer	20

blood draw	17
doctor visit	691
hospital care	27
inpatient care	27
lab tests	325
minimally invasive procedures	83
urologic procedures	316

**Gender**
Male	690
Female	148

**Ethnicity**
Non-Hispanic White	746
Black	0
Hispanic	0
Asian	0
Other	0
Native American	26

**Age**
From 65 to 74	426
From 75 to 84	242
85 and over	84
Less than 65	86

Hypertension	58
High Cholesterol	43
Stroke	5
Ischemic Heart Disease	31
Depression	16
Chronic Kidney Disease	29
Asthma	9
Osteoperosis	4
Atrial Fibrilation	14
Heart Failure	14
Chronic Obstructive Pulmonary Disease	10
Diabetes	24
Dementia	8
Cancer	21

blood draw	34
doctor visit	669
hospital care	41
inpatient care	41
lab tests	199
minimally invasive procedures	80
stent placement (stenting)	12
urologic procedures	224

**Gender**
Male	328
Female	64

**Ethnicity**
Non-Hispanic White	356
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	191
From 75 to 84	123
85 and over	41
Less than 65	37

Hypertension	56
High Cholesterol	41
Stroke	6
Ischemic Heart Disease	29
Depression	18
Chronic Kidney Disease	31
Asthma	12
Osteoperosis	5
Atrial Fibrilation	11
Heart Failure	16
Chronic Obstructive Pulmonary Disease	9
Diabetes	23
Dementia	9
Cancer	21

blood draw	39
doctor visit	600
lab tests	301
minimally invasive procedures	54
urologic procedures	238

**Gender**
Male	304
Female	53

**Ethnicity**
Non-Hispanic White	319
Black	0
Hispanic	0
Asian	0
Other	16
Native American	0

**Age**
From 65 to 74	170
From 75 to 84	118
85 and over	38
Less than 65	31

Hypertension	52
High Cholesterol	34
Stroke	4
Ischemic Heart Disease	32
Depression	15
Chronic Kidney Disease	27
Asthma	6
Osteoperosis	3
Atrial Fibrilation	11
Heart Failure	13
Chronic Obstructive Pulmonary Disease	8
Diabetes	19
Dementia	9
Cancer	19

blood draw	19
diagnostic procedures	12
doctor visit	700
lab tests	257
minimally invasive procedures	102
minor procedures	12
potassium test	16
urologic procedures	377

**Gender**
Male	318
Female	58

**Ethnicity**
Non-Hispanic White	339
Black	0
Hispanic	0
Asian	0
Other	12
Native American	0

**Age**
From 65 to 74	191
From 75 to 84	121
85 and over	39
Less than 65	25

Hypertension	54
High Cholesterol	43
Stroke	4
Ischemic Heart Disease	29
Depression	18
Chronic Kidney Disease	27
Asthma	4
Osteoperosis	5
Atrial Fibrilation	13
Heart Failure	16
Chronic Obstructive Pulmonary Disease	9
Diabetes	19
Dementia	7
Cancer	18

blood draw	18
doctor visit	743
hospital care	15
inpatient care	15
lab tests	326
minimally invasive procedures	131
neurostimulation	31
urologic procedures	374

**Gender**
Male	399
Female	81

**Ethnicity**
Non-Hispanic White	434
Black	0
Hispanic	15
Asian	0
Other	19
Native American	0

**Age**
From 65 to 74	261
From 75 to 84	136
85 and over	42
Less than 65	41

Hypertension	52
High Cholesterol	46
Stroke	7
Ischemic Heart Disease	32
Depression	19
Chronic Kidney Disease	31
Asthma	5
Osteoperosis	4
Atrial Fibrilation	12
Heart Failure	17
Chronic Obstructive Pulmonary Disease	9
Diabetes	24
Dementia	8
Cancer	20

catheterization	14
diagnostic procedures	29
doctor visit	1139
foreign body removal	18
hormone therapy	18
lab tests	350
laser treatment	12
lithotripsy (stone fragmentation)	13
minimally invasive procedures	240
minor procedures	29
neurostimulation	14
stent placement (stenting)	30
urologic procedures	644

**Gender**
Male	595
Female	77

**Ethnicity**
Non-Hispanic White	631
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	416
From 75 to 84	194
85 and over	23
Less than 65	39

Hypertension	55
High Cholesterol	58
Stroke	4
Ischemic Heart Disease	36
Depression	17
Chronic Kidney Disease	29
Asthma	6
Osteoperosis	5
Atrial Fibrilation	10
Heart Failure	10
Chronic Obstructive Pulmonary Disease	8
Diabetes	19
Dementia	5
Cancer	26

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Michael T. Lavelle JR., MD for Medicare patients.

The highest averages for the top procedures that Dr. Michael T. Lavelle JR., MD treated as an urologist in Bend, OR were urologic procedures, lab tests, minimally invasive procedures and minor procedures.

ablation	13
anorectal procedures	20
blood draw	23
catheterization	14
cryotherapy	13
diagnostic procedures	49
doctor visit	943
foreign body removal	27
hormone therapy	48
hospital care	30
inpatient care	30
lab tests	354
laser treatment	30
lithotripsy (stone fragmentation)	24
minimally invasive procedures	175
minor procedures	52
neurostimulation	25
potassium test	23
stent placement (stenting)	39
urologic procedures	519

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Michael T. Lavelle JR., MD.

**Gender**
Male	321
Female	64

**Ethnicity**
Black / African American	0
Asian / Pacific Islander	0
Non-Hispanic White	350
Native American / Alaskan Native	2
Hispanic	1
Other	4

**Age**
75 to 84	117
85 and over	35
Less than 65	35
65 to 74	197

Average of Total of Conditions of Medicare patients treated by Dr. Michael T. Lavelle JR., MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Michael T. Lavelle JR., MD treated were hypertension, high cholesterol, ischemic heart disease and chronic kidney disease.

Hypertension	43
High Cholesterol	34
Stroke	4
Ischemic Heart Disease	25
Depression	14
Chronic Kidney Disease	23
Asthma	5
Osteoporosis	3
Heart Failure	11
Chronic Obstructive Pulmonary Disease	7
Diabetes	17
Atrial Fibrillation	9
Cancer	16
Dementia	6

Education & Training

Dr. Michael T. Lavelle JR., MD graduated from Loyola University Chicago, Stritch School of Medicine in 2005. He completed residency at Oregon Health & Science University Affiliated Hospitals. He has a state license in Oregon.

Medical School: Loyola University Chicago, Stritch School of Medicine (2005)

Residency: Oregon Health & Science University Affiliated Hospitals (2005)

Licensed In: Oregon

Affiliations & Hospitals

Dr. Michael T. Lavelle JR., MD is associated with these hospitals and organizations:

St. Charles Health System

PRAXIS HEALTH PC

ST CHARLES HEALTH SYSTEM INC

Ratings & Reviews

Dr. Michael T. Lavelle JR., MD has a high overall rating with an average of 4.25 out of 5 stars based on 2 ratings. We collect ratings and reviews of Dr. Michael T. Lavelle JR., MD from all over the web to help you find the right in Bend, OR.

4.25

Overall Rating

(2 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Michael T. Lavelle JR., MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Valeant Pharmaceuticals North America LLC	$4,112 PROVENGE $4,112
Astellas Pharma US Inc	$1,873 XTANDI $677	Myrbetriq $606	Vesicare $300	$289
Bayer HealthCare Pharmaceuticals Inc.	$420 Xofigo $374	Nubeqa $46
Janssen Biotech, Inc.	$402 ZYTIGA $267	Erleada $121	Balversa $14
Allergan Inc.	$395 BOTOX $236	Botox Therapeutic $146	NATRELLE IMPLANTS $13
Other	$4,531 Urolift $331	ZYTIGA $328	XTANDI $319	RAPAFLO $272	PROVENGE $259	Other $3,022

**Types of Payments**
Food and Beverage	$7,269
Consulting Fee	$3,000
Travel and Lodging	$1,027
Education	$438

Biography

Dr. Michael Lavelle practices urology (urinary tract disease). Dr. Lavelle's education and training includes medical school at Loyola University Chicago, Stritch School of Medicine and residency at a hospital affiliated with Oregon Health & Science University. He is affiliated with St. Charles Health System.

Select Year:

Dr. Michael T. Lavelle JR., MD

Office Locations

Some issues Dr. Michael T. Lavelle JR., MD can help you with:

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

2013 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael T. Lavelle JR., MD in 2013

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

2014 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael T. Lavelle JR., MD in 2014

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

2015 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael T. Lavelle JR., MD in 2015

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

2016 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael T. Lavelle JR., MD in 2016

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

2017 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael T. Lavelle JR., MD in 2017

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

2018 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael T. Lavelle JR., MD in 2018

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

2019 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael T. Lavelle JR., MD in 2019

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

2020 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael T. Lavelle JR., MD in 2020

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

Average Medicare Procedure Volume From 2013 - 2021

Average Medicare Patient Data From 2013 - 2021

Average of Total of Conditions of Medicare patients treated by Dr. Michael T. Lavelle JR., MD From 2013 - 2021

Education & Training

Affiliations & Hospitals

Ratings & Reviews

General Payments

Biography

Other Providers in Bend, OR